BRKR (Bruker) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BRKR Bruker Corp BRKR
85 GF Score
Price $61.38
GF Value $60.37
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Bruker Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Bruker  (NAS:BRKR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bruker Cyclically Adjusted PB Ratio Related Terms


Bruker Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Bruker's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bruker Cyclically Adjusted PB Ratio Chart

Bruker Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.11 10.44 10.39 7.46 5.17

Bruker Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.15 3.91 5.51 4.03 6.45

BRKR vs PODD, BIO, GKOS: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Bruker's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bruker Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bruker's Cyclically Adjusted PB Ratio falls into.


BRKR
85GF Score
Bruker Corp BRKR
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bruker Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bruker's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Bruker's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=15.988/333.9520*333.9520
=15.988

Current CPI (Jun. 2026) = 333.9520.

Bruker Quarterly Data

Book Value per Share CPI Adj_Book
201609 4.370 241.428 6.045
201612 4.336 241.432 5.998
201703 4.574 243.801 6.265
201706 4.804 244.955 6.549
201709 4.738 246.819 6.411
201712 4.706 246.524 6.375
201803 5.063 249.554 6.775
201806 5.024 251.989 6.658
201809 5.272 252.439 6.974
201812 5.924 251.233 7.874
201903 6.017 254.202 7.905
201906 5.768 256.143 7.520
201909 5.688 256.759 7.398
201912 6.086 256.974 7.909
202003 5.995 258.115 7.756
202006 5.922 257.797 7.671
202009 6.285 260.280 8.064
202012 6.410 260.474 8.218
202103 6.478 264.877 8.167
202106 6.724 271.696 8.265
202109 7.185 274.310 8.747
202112 7.196 278.802 8.619
202203 6.954 287.504 8.077
202206 6.679 296.311 7.527
202209 6.472 296.808 7.282
202212 7.698 296.797 8.662
202303 8.250 301.836 9.128
202306 8.600 305.109 9.413
202309 8.528 307.789 9.253
202312 9.736 306.746 10.600
202403 9.982 312.332 10.673
202406 12.052 314.175 12.811
202409 12.158 315.301 12.877
202412 11.967 315.605 12.663
202503 12.217 319.799 12.758
202506 12.305 322.561 12.740
202509 16.463 324.800 16.927
202512 16.500 324.054 17.004
202603 16.442 330.213 16.628
202606 15.988 333.952 15.988

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Bruker (BRKR) Overvalued in 2026?

Based on GuruFocus' analysis, Bruker stock appears to be overvalued. The current stock price of $61.38 is trading 1.7% above its estimated GF Value™ of $60.37. GuruFocus considers Bruker to be Fairly Valued.

Key valuation signals for BRKR:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $60.37 vs. price of $61.38 (1.7% above fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the BRKR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bruker Business Description

Address 40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
85GF Score

Get the complete analysis for BRKR

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$61.38
Price
$60.37
GF Value